ALK is a global research-driven pharmaceutical company that focuses on prevention, diagnosis and treatment of allergies. Since 1923 ALK has been working to improve the quality of life for allergy patients by developing drugs that target the cause of allergy. ALK is a world leader in allergy immunotherapy – a unique treatment of the cause of allergies.

For more information, visit ALK Abello’s website: https://www.alk.net/